Related Experiment Video
Updated: Feb 17, 2026

07:12
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
Published on: October 26, 2017
8.2K
Total Synthesis of Reniochalistatin E.
Anthony Fatino1, Giovanna Baca1, Chamitha Weeramange1
1Department of Chemistry, Kansas State University , Manhattan, Kansas 66506, United States.
Journal of Natural Products
|December 9, 2017
Summary
Researchers synthesized Reniochalistatin E, a cyclic peptide from a marine sponge, for the first time. The synthetic compound showed similar cytotoxicity to the natural form, enabling further structure-activity relationship studies.
Area of Science:
- Marine natural products chemistry
- Organic synthesis
- Medicinal chemistry
Background:
- Reniochalistatin E is a cyclic peptide isolated from the marine sponge Reniochalina stalagmitis.
- It is unique among related compounds for containing a tryptophan residue.
- Cytotoxicity was observed in initial studies of Reniochalistatin E.
Purpose of the Study:
- To develop the first total synthesis of Reniochalistatin E.
- To enable structure-activity relationship (SAR) studies of Reniochalistatin E.
- To facilitate further biological investigations of Reniochalistatin E and its analogs.
Main Methods:
- A 15-step synthetic route was designed and executed for Reniochalistatin E.
- The total synthesis achieved an overall yield of 5.0%.
- Cytotoxicity assays were performed on HeLa and RPMI-8226 cell lines.
Main Results:
- The first total synthesis of Reniochalistatin E was successfully completed.
- Synthetic Reniochalistatin E exhibited comparable cytotoxicity to the natural product in cell line assays.
- Deprotected octapeptide intermediates also demonstrated cytotoxic activity.
Conclusions:
- The established synthetic route provides access to Reniochalistatin E for SAR studies.
- The findings support further exploration of Reniochalistatin E's biological activity.
- The synthesis opens avenues for developing novel bioactive marine natural products.
Related Concept Videos
Ribozymes
3.5K
3.5K
Ribozymes
13.5K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.5K
Synthesis of α-Substituted Carbonyl Compounds: The Stork Enamine Reaction
4.2K
α-Substituted ketones or aldehydes can be synthesized from enamines by the Stork enamine reaction, named after its pioneer Gilbert Stork. Enamines are useful synthetic intermediates where the lone pair on nitrogen is in conjugation with the C=C bond. They resemble enolate ions, as the resonance forms of both species have a nucleophilic α carbon.
4.2K
Ribosomal RNA Synthesis
14.9K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.9K
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K

